Radioactive therapy trial shrinks glioblastoma by half

Paul Read, a trial participant. Handout: Marie Mangan/UCLH/PA Wire

By Jane Kirby, PA Media

A man has seen his glioblastoma shrink by half thanks to a new radioactive therapy, which experts hope will "transform treatment”.

Doctors at University College London Hospitals NHS Foundation Trust (UCLH) are running a clinical trial to treat the cancer, which kills most patients within 18 months.